
Investor Alert: Faruqi & Faruqi Law Firm Investigates Potential Lawsuit Against ESSA Pharma for Misleading Investors
Securities Litigation: ESSA Pharma Investors Encouraged to Contact Faruqi & Faruqi, LLP Investors who have suffered losses after investing in ESSA Pharma Inc. (NASDAQ: ESSA) are encouraged to contact James (Josh) Wilson, a securities litigation partner at Faruqi & Faruqi, LLP. Wilson and his team are investigating potential securities laws violations at the company. Background…